Skip to content

Influence of FSH/LH Ratio in Controlled Ovarian Stimulation

Influence of FSH/LH Ratio in Controlled Ovarian Stimulation ( 2/1 Ratio vs 4/1 Ratio) in >35 Years Women Undergoing IVF

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02994550
Enrollment
447
Registered
2016-12-16
Start date
2017-01-31
Completion date
2018-01-31
Last updated
2022-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sub-Fertility

Keywords

FSH, LH, IVF

Brief summary

The aim of this study is to compare different FSH/LH ratios in controlled ovarian stimulation

Interventions

DRUGFSH/LH

Sponsors

Hospital de Cruces
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing IVF cycles in Cruces University Hospital. * Signed IVF and cryopreservation informed consent. * Age \>35 and \<40 years. * FSH levels \<10 mIU/ml.

Exclusion criteria

* When inclusion criteria are not fulfilled

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy achievement3 months after drug administrationTo report our results in terms of pregnancy per embryo transfer

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026